Screener
TG Therapeutics TGTX Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current liabilities | 268,493 | 153,760 |
| Deferred revenue, non-current portion | 14,525 | 8,807 |
| Loan payable – non-current | 745,387 | 245,645 |
| Lease liability – non-current | 7,141 | 7,021 |
| Total liabilities | $1,035,546 | $415,233 |
| Commitments and contingencies | ||
| Stockholders’ equity: | ||
| Common stock, $0.001 par value per share (190,000,000 and 190,000,000 shares authorized, 159,949,330 and 158,849,596 shares issued, 153,077,784 and 155,305,953 shares outstanding at June 30, 2026 and December 31, 2025, respectively) | 160 | 159 |
Document
FAQ
- What is TG Therapeutics's operating lease liabilities?
- TG Therapeutics (TGTX) reported operating lease liabilities of $7.14M in Q2 2026.
- How has TG Therapeutics's operating lease liabilities changed year-over-year?
- TG Therapeutics's operating lease liabilities decreased by 5.9% year-over-year, from $7.59M to $7.14M.
- What is the long-term trend for TG Therapeutics's operating lease liabilities?
- Over 5 years (2020 to 2025), TG Therapeutics's operating lease liabilities has grown at a -7.6% compound annual growth rate (CAGR), from $10.41M to $7.02M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about TG Therapeutics's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude